Market revenue in 2023 | USD 575.1 million |
Market revenue in 2030 | USD 822.3 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Synthetic/ blend of natural & synthetic |
Fastest growing segment | Natural |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Natural, Synthetic/ Blend of Natural & Synthetic |
Key market players worldwide | Fairhaven Health, Vitabiotics, Mankind Pharma, extreme V, Coast Science, Orthomol, Exeltis, bioNova, Innovamed, PlusPlus LifeSciences, Eu Natural |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fertility supplements market will help companies and investors design strategic landscapes.
Synthetic/ blend of natural & synthetic was the largest segment with a revenue share of 88.91% in 2023. Horizon Databook has segmented the U.S. fertility supplements market based on natural, synthetic/ blend of natural & synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Health Organization, several factors, including rising alcohol and tobacco consumption, a rise in the obese population, and elevated stress levels leading to hormonal imbalances, are responsible for the rising incidence of infertility in the U.S.
For instance, in January 2022, data released by the U.S. HHS, 40.5% of males over the age of 20 were obese, 15.3% of men over the age of 18 smoked frequently, 30.9% of men over the age of 18 drank five or more drinks in a single day, and 51.9% of men over the age of 20 had hypertension.
Over the past ten years, the use of ART (Assisted Reproductive Technology) has more than doubled, despite the fact that it is still comparatively uncommon when compared to potential demand. Every year, 2.3% of all babies born in the U.S. are conceived with the use of assisted reproductive technology.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. fertility supplements market , including forecasts for subscribers. This country databook contains high-level insights into U.S. fertility supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account